Operational Team

Ian Cooke

Jul 22, 2018

Head of Investment Committee

Dr Ilian Iliev

Jul 23, 2018

Managing Director

Vyara Stoycheva

Jul 24, 2018

Investment Manager

Oliver Saban

Jul 24, 2018

Head of Business Development

Harry Miller

Jul 27, 2018

Investment Associate

Nick Salisbury

Jan 13, 2020

Head of Private Clients

Stefan Nahum

Oct 28, 2020

Life Sciences & Healthcare Analyst

Venture Partners and Advisors

Chris Niehaus

Jul 23, 2018

Igor Turevsky

Jul 23, 2018

Prof. Nelson Philips

Jul 26, 2018

Kevin Dean

Apr 29, 2020

Spartak Kabakchiev

May 01, 2020


Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution.
It should be done only as part of a diversified portfolio. Any investments are targeted exclusively at investors who understand the risks of investing in early-stage businesses and can make their own investment decisions. Any pitches for investment are not offers to the public.

Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk